Table 2 Association between Severe Respiratory Failure and Immune Classification among Patients with COVID-19 and Patients with Sepsis Caused by Bacterial CAP
Number of patients with SRF/total patients [%, (−95% CI, +95% CI)] p value∗
Bacterial CAP COVID-19
Intermediate 21/40 [52.5 (27.5-67.1)] 0/26 [0 (0-12.9)] <0.0001
Immunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] <0.0001
∗comparisons by the Fisher exact test. Abbreviation is as follows: CI, confidence interval.